Can AI Fix What’s Been Broken in Clinical Trials?

Jul 11, 2025
1 min read

Updated: Feb 5

For decades, clinical trials have left out the communities most affected by disease. The result? Biased data, widening health disparities, and slower progress for everyone.

But what if AI could help rewrite that story?

Our latest white paper explores how artificial intelligence is becoming a powerful tool in making clinical research more equitable—and more effective.

Inside the Paper:

How AI can uncover historical bias in clinical trial data
Ways to improve participant diversity using real-world data
Tools to redesign trials for better representation and outcomes

With insights from The Lancet, Nature Medicine, and PLOS Digital Health—plus real-world case studies from Rubix LS and Stanford—we take a clear-eyed look at what’s working, what’s not, and what’s next.

This isn’t just about adopting new tech. It’s about building a better clinical research system—one that works for everyone.